By clicking "Continue," you confirm that you have reviewed the CME information.
Faculty
Wanda Phipatanakul, MD, MS
Professor of Pediatrics
Harvard Medical School
Director, Clinical Research Center
Division of Asthma, Allergy, Dermatology, Rheumatology, and Immunology
Boston Children's Hospital
Boston, MA
Michael Wechsler, MD
Professor of Medicine
Director, NJH Cohen Family Asthma Institute
Department of Medicine
National Jewish Health
Denver, CO
Activity Planners
Julie Blum, PhD
Director, Clinical Content
Med-IQ
Baltimore, MD
Samantha Gordon, MS
Accreditation Manager
Med-IQ
Baltimore, MD
Amy Sison
Director of CME
Med-IQ
Baltimore, MD
Kathryn Schaefer, MSN, RN, CPHRM, CHCP
Associate Director, Education Quality and Compliance
Med-IQ
East Lansing, MI
Learning Objectives
Upon completion, participants should be able to:
Target Audience
This activity is intended for healthcare providers in primary care and pediatric practices, including primary care physicians, pediatricians, nurse practitioners, physician assistants, and nurses.
Statement of Need
Asthma is a complex, heterogeneous, and common respiratory disorder that affects approximately 8% of the United States population. Nearly one-half of these individuals report uncontrolled disease, resulting in substantial morbidity and serious reductions in quality of life (QOL). Wide variability in severity is seen across the asthma population and within individuals over time, with severity strongly influencing QOL, activities of daily living, social exclusion, and health outcomes. Patients with severe asthma face many challenges, including diagnostic delays, stigmatization, and misconceptions surrounding the disease; furthermore, they are often ill informed regarding asthma, disease severity, available management options, and self-management strategies. Additionally, patient-provider goals and expectations often do not align.
Although multiple evidence-based recommendations support a methodical and comprehensive approach to assessment and management, including timely referral to an asthma specialist, adherence to guidelines remains suboptimal. Moreover, many providers lack knowledge surrounding the integration of new, targeted agents into personalized approaches to asthma management.
Providership Statement
Provided by Med-IQ.
Accreditation/Designation Statements
Med-IQ is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Med-IQ designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Instructions to Receive Credit
To receive credit, read the introductory CE material, watch the webcast, and complete the evaluation, attestation, and post-test, answering at least 70% of the post-test questions correctly.
Initial Release Date: October 21, 2021
Expiration Date: October 20, 2022
Estimated Time to Complete This Activity: 1 hour
The peer reviewers and activity planners have no financial relationships to disclose.
Statement of Evidence-Based Content
Educational activities that assist physicians in carrying out their professional responsibilities more effectively and efficiently are consistent with the ACCME definition of continuing medical education (CME). As an ACCME-accredited provider of CME, Med-IQ has a policy to review and ensure that all the content and any recommendations, treatments, and manners of practicing medicine in CME activities are scientifically based, valid, and relevant to the practice of medicine. Med-IQ is responsible for validating the content of the CME activities it provides. Specifically, (1) all recommendations addressing the medical care of patients must be based on evidence that is scientifically sound and recognized as such within the profession; (2) all scientific research referred to, reported, or used in CME in support or justification of a patient care recommendation must conform to generally accepted standards of experimental design, data collection, and analysis.
Med-IQ is not liable for any decision made or action taken in reliance upon the information provided through this activity.
Contact Information
For questions or comments about this activity, please contact Med-IQ. Call (toll-free) 866 858 7434 or email info@med-iq.com.
System Requirements
Desktop
Mobile
Applications & Software
For technical assistance, please refer to our Support Manual.
Disclaimer
The information provided through this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition.
Privacy & Confidentiality
Med-IQ is committed to honoring your privacy and protecting any personal information you choose to share with us. For detailed information about our privacy policy, please visit: www.med-iq.com/privacy-notice.
Complimentary CE
This activity is available free of charge to participants.
Acknowledgment of Commercial Support
This activity is supported by an educational grant from Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme.
Copyrighted
PDF: Handouts
By clicking "Continue," you confirm that you have reviewed the CME information.
Unless otherwise indicated, photographed subjects who appear within the content of this activity or on artwork associated with this activity are models; they are not actual patients or doctors.
The information provided through this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition.
COPYRIGHTED. Republication or redistribution of Med‑IQ content, including by framing, is prohibited without prior written consent. Med‑IQ shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.